Skip to main content
. 2019 Nov 26;9:17576. doi: 10.1038/s41598-019-54171-5

Figure 5.

Figure 5

Representative images taken with slit lamp bio-microscopy, ICGA and ASOCTA at the weekly time-points for ranibizumab group. At week 3 time-point, the eyes were administered with ranibizumab. (a) Shows the sequence of images captured for rabbit injected with aflibercept through sub-conjunctival route, whereas (b) represents image sequence for rabbit instilled with ranibizumab eye-drops.